Latest Alkynes Stories
A team of Brazilian scientists has identified a promising new combination treatment that targets cervical cancer, according to a new report published in the journal Cancer.
Roger Denton, Plaintiffs' Lead Counsel and one of the lead negotiators for the plaintiffs in the NuvaRing® MDL, reports that a $100 Million settlement has been reached with Merck to settle
The investigational drug AZD9291, a third-generation EGFR inhibitor, showed promise in preclinical studies and provides hope for patients with advanced lung cancers that have become resistant to existing EGFR inhibitors.
BioPlus selected as a specialty pharmacy for the new Tarceva network; now authorized to dispense this oncology medication. Altamonte Springs, FL (PRWEB) June
- Growing in low tufty patches.